1) light chain multiple myeloma
多发性骨髓瘤/轻链型
2) Light-chain multiple myeloma hairstyle
轻链型多发型骨髓瘤
3) multiple myeloma
多发性骨髓瘤
1.
An analysis of ocurrence and prognosis related factors of renal dysfunction in patients with multiple myeloma.;
多发性骨髓瘤肾功能损害及预后相关因素研究
2.
The influence of vascular endothelial growth factor on secretion of interleukin-6 of bone marrow stromal cells in multiple myeloma;
VEGF对多发性骨髓瘤骨髓基质细胞分泌IL-6的影响
3.
Effects of arsenic trioxide on the biological characteristics of multiple myeloma cell line RPMI8226;
三氧化二砷对多发性骨髓瘤细胞生物学特性的影响
4) Multiple Myeloma(MM)
多发性骨髓瘤
1.
Objective:To investigate the application of immunoglobulin heavy chain(IgH) gene rearrangement in the diagnosis and therapy of multiple myeloma(MM).
目的:探讨免疫球蛋白重链(IgH)基因重排在多发性骨髓瘤(MM)患者治疗过程中监测的临床意义。
2.
Objective To explore whether there is any association between multiple myeloma(MM)and the infection of Borna disease virus(BDV).
目的探讨Borna病病毒(BDV)感染与人类多发性骨髓瘤(MM)发病的关系。
3.
Objective To estimate the prevalence of depression and anxiety in patients with multiple myeloma(MM)and to analyze the possible impact factors.
目的评估多发性骨髓瘤(MM)患者伴抑郁、焦虑情绪的发生率,并分析其相关的影响因素。
5) MM
多发性骨髓瘤
1.
Detection and clinical significance of serumβ_2-MG、CRP level in MM;
多发性骨髓瘤患者血清β_2-M、CRP水平的测定及临床意义
2.
Objective: Aim Discussing the clinical characters,diagnosis,therapies,prognosis and some concerning factors of MM,discussing the reason of the error diagnosis,concluding the experience of the diagnosis and therapies.
目的:探讨多发性骨髓瘤的临床特点、诊断、治疗及预后等相关因素,探讨误诊的原因,总结诊断和治疗的经验。
3.
Methods Monocytic cells of bone marrow samples from 24 cases with acute lymphoblastic leukemia(ALL),15 cases with multiple myeloma(MM),26 cases with non-Hodgkins lymphoma(NHL),4 cases with chronic lymphocytic leukemia(CLL),4 cases with Hodgkins lymphoma(HD) and 16 healthy persons were measured by immunological fluores.
方法 用免疫荧光方法检测 2 4例急性淋巴细胞白血病 (acutelymphoblasticleukemia ,ALL) ,15例多发性骨髓瘤 (multi plemyeloma ,MM) ,2 6例非霍杰金氏淋巴瘤 (non Hodgkinslymphoma ,NHL) ,4例慢性淋巴细胞白血病 (chroniclymphocyticleukemia ,CLL) ,4例霍杰金氏淋巴瘤 (Hodgkinslymphoma)及 16例正常人造血干细胞CD+ 3 4细胞表面CD5 4的表达。
6) multiple myeloma (MM)
多发性骨髓瘤
1.
Objective To determinate the concentrations of angiognic factors of bone marrow (BM) in multiple myeloma (MM) patients at different clinical stage,to analyze the relationships between angiogenesis and clinical status.
目的测定不同临床阶段多发性骨髓瘤(MM)患者骨髓中血管新生因子的水平,分析其与疾病-临床分期之间的关系。
2.
1dele ted in multiple myeloma (MM)patients,the expressed sequence ta gs(ESTs )which represent the novel gene in thi s region were obtained by bioinformatics analysis,then its expression was detected by semi-quantitative reverse tran-scription -polymerase chain reaction(RT-PCR).
为克隆位于多发性骨髓瘤(multiplemyeloma,MM)患者染色体13q14。
3.
Aim:To improve differential diagnosis by imaging(X-ray and CT) between multiple myeloma (MM) and metastatic tumor of bone.
目的：为了提高对多发性骨髓瘤（ Ｍ Ｍ） 和骨转移瘤的影像学（ Ｘ 线、 Ｃ Ｔ） 的鉴别诊断水平。
补充资料：多发性骨髓瘤性肾病
多发性骨髓瘤性肾病
multiple myeloma nephropathy
继发于多发性骨髓瘤的肾损害。骨髓瘤可由多种途径损害肾脏，包括：①凝溶蛋白对肾小管的损害；②轻链在肾小球系膜区的沉积；③继发肾淀粉样变；④溶骨引起的高钙性肾病及瘤组织破坏引起的高尿酸肾病等。治疗应以治疗骨髓瘤为主。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条